X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Health & Nutrition

Danone partners with digital oncology company Resilience for better nutritional care for patients with cancer

Content Team by Content Team
13th January 2024
in Health & Nutrition, News
Danone partners with digital oncology company Resilience for better nutritional care for patients with cancer

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Nutrition information and support during cancer care

Danone partners with digital oncology company Resilience for better nutritional care for patients with cancerNutrition information and support during cancer care

According to a recent Ipsos survey commissioned by Danone, 64% of patients with cancer in Europe report nutritional problems that include loss of appetite, dry mouth, and nausea3. These symptoms often lead to weight loss and malnutrition, disrupting treatment plans, and affecting overall quality of life, recovery, and treatment outcomes.

83% of patients deem nutrition an essential topic for their medical care, yet many struggle to identify where to look for advice when they experience eating problems or lose weight. The survey also shows that access to nutritional information during treatment remains irregular. One in four patients say they have not received help or advice in this area, while many do their own research on nutrition. It is crucial to ensure patients have access to credible and timely nutrition advice to support their treatment outcomes.

A partnership at the intersection of digital health and nutrition

Danone is proud to announce a new partnership with Resilience for the development of a nutrition support module for patients with cancer that is now integrated in the Resilience digital oncology solution.

Resilience is a remote patient care solution. Through its platform used by healthcare professionals and its mobile application dedicated to patients with cancer, Resilience combines patient monitoring and tools to help manage treatment-related side effects in a comprehensive solution. Its remote monitoring medical device is now recognized by the French health authorities for all adult patients undergoing systemic cancer treatment. Danone is committed to bringing health through food to as many as possible, also during critical times in life. As a longstanding pioneer in medical nutrition, the company collaborates with healthcare professionals, patient associations and other partners, so that nutrition becomes an integral part of healthcare.

This partnership combines Danone’s expertise about the role of nutrition during illness and health with Resilience’s ability to reinvent patient care and drive the digital healthcare transition. As part of this partnership, Danone’s researchers and medical experts shared findings from peer-reviewed clinical research, and scientific literature and other resources on nutrition during cancer.

Katrien van Laere, Senior VP R&I and Medical Nutritional Science for Danone comments on the partnership: “We are proud to partner with Resilience and share all we have learnt over the years about the role of nutrition in cancer. With partnerships like these we hope to contribute to patient wellbeing and better outcomes for everyone impacted by cancer every day. We are excited Resilience is expanding its digital oncology solutions with evidence-based nutrition modules and screening tools.”

Previous Post

Komodo Health Collaborates With Robert Wood Johnson Foundation To Advance New Research on Diet and Health

Next Post

The Digital Transition Pharma Landscape Is Going Through

Related Posts

WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Construction of WuXi Biologics Microbial Manufacturing Site
News

Construction of WuXi Biologics Microbial Manufacturing Site

19th June 2025
Beyfortus From Sanofi to Make Imprint in 2025 26 RSV Season
News

Beyfortus From Sanofi to Make Imprint in 2025-26 RSV Season

19th June 2025
Thermo-Fischer-Accelerator Drug Development an Ideal Choice
News

Thermo Fischer Accelerator Drug Development an Ideal Choice

19th June 2025
IQVIA Custom Built AI Agents for Life Sciences Healthcare
News

IQVIA Custom-Built AI Agents for Life Sciences, Healthcare

19th June 2025
SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Next Post

The Digital Transition Pharma Landscape Is Going Through

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In